Portfolio concentration
As of April 30, 2026 · N-PORT
Holdings
29
Top-10 weight
48.96%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
25
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1049.6
Holdings
As of April 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DEL | — | 5,543 | $3.17M | 6.40% |
| 2 | CARDINAL HEALTH INC | — | 14,297 | $2.76M | 5.57% |
| 3 | JAZZ PHARMACEUTI | — | 12,812 | $2.60M | 5.25% |
| 4 | Novartis AG | — | 16,784 | $2.48M | 5.01% |
| 5 | CENCORA INC | — | 8,034 | $2.47M | 5.00% |
| 6 | AMGEN INC | — | 7,077 | $2.45M | 4.95% |
| 7 | Mount Vernon Liquid Assets Portfolio, LLC | — | 2,425,936 | $2.43M | 4.90% |
| 8 | MCKESSON CORP | — | 2,973 | $2.42M | 4.89% |
| 9 | EXELIXIS INC | — | 52,445 | $2.33M | 4.71% |
| 10 | REGENERON PHARMACEUTICALS INC | — | 3,260 | $2.31M | 4.66% |
| 11 | LANTHEUS HOLDING | — | 26,355 | $2.23M | 4.50% |
| 12 | JOHNSON&JOHNSON | — | 8,261 | $1.90M | 3.83% |
| 13 | BRISTOL-MYERS SQUIBB CO | — | 30,000 | $1.82M | 3.67% |
| 14 | THE CIGNA GROUP | — | 6,051 | $1.76M | 3.55% |
| 15 | GILEAD SCIENCES INC | — | 13,391 | $1.75M | 3.54% |
| 16 | NATL HEALTHCARE | — | 9,612 | $1.67M | 3.36% |
| 17 | VERTEX PHARMACEUTICALS INC | — | 3,831 | $1.64M | 3.31% |
| 18 | INTUITIVE SURGICAL INC | — | 3,517 | $1.61M | 3.25% |
| 19 | US ULTRA BOND CBT Sep25 | — | 1,575,546 | $1.58M | 3.18% |
| 20 | MEDPACE HOLDINGS INC | — | 3,593 | $1.50M | 3.04% |
| 21 | MERCK & CO | — | 13,629 | $1.49M | 3.01% |
| 22 | INCYTE CORP | — | 15,511 | $1.48M | 2.98% |
| 23 | STRYKER CORP | — | 3,396 | $1.07M | 2.16% |
| 24 | LABCORP HOLDINGS INC | — | 4,153 | $1.07M | 2.15% |
| 25 | MEDTRONIC PLC | — | 12,359 | $1.00M | 2.02% |
| 26 | LILLY ELI and CO | — | 970 | $906.56K | 1.83% |
| 27 | OPTION | NVO US | 19,907 | $840.47K | 1.70% |
| 28 | ELEVANCE HEALTH INC | — | 1,621 | $610.18K | 1.23% |
| 29 | ENSIGN GROUP INC | — | 3,141 | $586.39K | 1.18% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.